PHARMACO-KINETICS OF MELPHALAN FOLLOWING ORAL OR INTRAVENOUS ADMINISTRATION IN PATIENTS WITH MALIGNANT DISEASE

被引：101

作者：

TATTERSALL, MHN

JARMAN, M

NEWLANDS, ES

HOLYHEAD, L

MILSTEAD, RAV

WEINBERG, A

机构：

[1] CHARING CROSS HOSP,DEPT MED ONCOL,LONDON W6 8RF,ENGLAND

[2] INST CANC RES,DIV CHEM,MASS SPECTROMETRY LAB,LONDON,ENGLAND

[3] BURROUGHS WELLCOME CO,DEPT IMMUNOL,SYDNEY,AUSTRALIA

来源：

EUROPEAN JOURNAL OF CANCER | 1978年 / 14卷 / 05期

关键词：

D O I：

10.1016/0014-2964(78)90253-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：507 / 513

页数：7

共 5 条

[1]

ALBERTS D, 1977, P AM ASSOC CANC RES, V18, P128

[2]

ALEXANIAN R, 1968, BLOOD, V31, P1

[3] 1-PHENYLALANINE MUSTARD (L-PAM) IN MANAGEMENT OF PRIMARY BREAST-CANCER - REPORT OF EARLY FINDINGS [J].

FISHER, B ;

CARBONE, P ;

ECONOMOU, SG ;

FRELICK, R ;

GLASS, A ;

LERNER, H ;

REDMOND, C ;

ZELEN, M ;

BAND, P ;

KATRYCH, DL ;

WOLMARK, N ;

FISHER, ER .

NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (03) :117-122

[4]

FURNER RL, 1977, P AM ASSOC CANC RES, V18, P41

[5]

SMITH JP, 1974, 42 NATL CANC I MON, P141

← 1 →